P18 Toremifene as a reference drug in the treatment of breast cancer von Tarutinov, V

Volltext

Expression of E-cadherin in drug resistant human breast cancer cells and their sensitivity to lymphokine-activated lymphocytes action von Berezhnaya, N M, Belova, O B, Vinnichuk, Yu D, Tarutinov, V I

Volltext

A phase III trial comparing adjuvant treatment with leuprorelin acetate 3M-Depot for 24 months with CMF chemotherapy in ER/PR + node + pre-perimenopausal breast cancer patients von Wallwiener, D., Possinger, K., Schmid, P., Tarutinov, V., Suchina, L., Hillger, H., Kienle, E., Maubach, L., Kahlert, S., Untch, M.

Volltext

A phase III trial comparing adjuvant treatment with leuprorelin acetate 3M-Depot for 24 months with CMF chemotherapy in ER/PR + node + pre-perimenopausal breast cancer patients von Wallwiener, D., Possinger, K., Schmid, P., Tarutinov, V., Suchina, L., Hillger, H., Kienle, E., Maubach, L., Kahlert, S., Untch, M.

Volltext

P954. Toremifene, tamoxifen and the dynamics of blood hormones in breast cancer patients' treatment von Tarutinov, V., Kasjanenko, I., Dosenko, I., isitza, A.

Volltext